NASDAQ OMX

IBFD and Tax Analysts Join Forces for Global Perspective on U.S. Tax Reform

27.6.2017 10:00 | NASDAQ OMX

Del

U.S. tax reform is high on the agenda.  The administration of U.S. President Donald Trump recently unveiled the core principles of  "the most significant tax reform since 1986". IBFD and Tax Analysts, the top two sources of expertise on U.S. and international taxation, have pooled their resources to offer a global perspective on U.S. tax reform in a special issue of the Bulletin for International Taxation.

AMSTERDAM, June 27, 2017 (GLOBE NEWSWIRE) -- IBFD and Tax Analysts share a mission: to promote the understanding of taxation and to foster open and informed debate. As independent, non-partisan and not-for-profit organizations, they have combined their extensive coverage and analysis of U.S. domestic and cross-border taxation, in order to examine the implications of U.S. tax reform both at home and abroad.

"It appears that the U.S. is embarking on the first major review and possible changes to the U.S. tax code in decades and everyone wants to better understand it," said Christopher Bergin, CEO of Tax Analysts. "That is why we exist, to provide timely news and in-depth analysis of major tax matters such as tax reform. By partnering with IBFD, we will help taxpayers globally understand the key measures and potential impact on them." 

"The combination of a Republican president and Republican majorities in both the House of Representatives and the Senate makes the enactment of comprehensive tax reform likely," explained Jan Maarten Slagter, CEO of IBFD. "This is why, together with Tax Analysts, we have produced a special issue of the Bulletin for International Taxation. Its 27 expert articles will go a long way to help tax professionals anticipate the potential complexities of the proposed measures. This  project marks the beginning of our combined efforts to further advance our shared mission."

"With growing globalization, taxation is often at the heart of national policies, as we are now seeing in the U.S.," said Maarten Goudsmit, IBFD's Director of Publishing. "In the end, it is the taxpayer, whether as an individual or as a corporation, who must adapt to the resulting changes in their practices. IBFD and Tax Analysts share an important role in providing the affected parties with the best possible answers to their questions. Over the past months, it has been a pleasure and a privilege to work with Tax Analysts to fulfil this role."

The Special Issue for the Bulletin of International Taxation provides a comprehensive and detailed analysis of the proposed reform measures and examines their impact on inbound and outbound investment activities and cross-border trade. The articles will also be published in parallel with the Tax Analyst platform. The Special Issue seeks to provide readers with answers to the following questions:

  • Investment location: Will the tax reform increase the attractiveness of the U.S. as an investment location? How will foreign investors be affected by the reform?
  • Tax structures and business models: How will the existing tax structures need to be adapted? How will border adjustments affect international trade? What will be their impact on outsourcing and offshoring structures?
  • International response: How will other countries respond to the U.S. tax reform?
  • Simplification and compliance: Will the tax reform simplify the U.S. tax system? Will the compliance burden be reduced?

About IBFD
IBFD is a leading international provider of cross-border tax expertise, with a long-standing history of supporting and contributing to tax research and academic activities. As an independent foundation, IBFD utilizes its global network of tax experts and its Knowledge Centre to serve Fortune 500 companies, governments, international consultancy firms and tax advisors. Headquartered in Amsterdam, IBFD has regional offices in Beijing, Washington and Kuala Lumpur. IBFD's Library and Information Centre is widely regarded as the world's leading research facility in the field of international and comparative taxation.

Renowned as the leading expertise portal in the field of cross-border taxation and legislation, IBFD's powerful Tax Research Platform allows tax practitioners around the world to access a wealth of reliable and valuable content, enabling faster and more effective work.

IBFD's complete coverage further includes courses, journals and books, and a Master's in International Tax Law (in collaboration with the University of Amsterdam). IBFD also offers government consultancy and individual client research services.

About Tax Analysts
Tax Analysts is the nonpartisan, nonprofit organization that publishes Tax Notes, the leading multimedia source of breaking news, in-depth analysis, and insightful commentary on tax administration and policy. Tax Analysts has the industry's largest tax-dedicated correspondent staff, with more than 250 domestic and international correspondents. Tax Analysts provides tax news and analysis for more than 150,000 tax professionals in law and accounting firms, corporations, and government agencies worldwide, as well as academics. All rely on Tax Analysts' federal, state, and international content daily. Key products include Tax Notes Tax Notes TodayState Tax NotesState Tax TodayTax Notes International , and Worldwide Tax Daily.

About the Bulletin for International Taxation
IBFD established the Bulletin for International Taxation (BIT) in 1946. This informative and well-respected journal examines tax policy changes and tax developments throughout the world and gives background and perspective to the changes.

In the Special Issue: A Global Perspective on the US Tax Reform, authors comment on the US tax reform from the perspective of their country or region (for example, China, India, Latin America, Brazil, Europe, the Netherlands, Germany, Belgium and Singapore) and address some topical issues relevant for international investors (border adjustment tax, territorial tax system, net investment income tax and profit repatriation).

The Special Issue features an impressive number of 27 articles (15 delivered by IBFD and 12 by Tax Analysts). Many of the articles were written by renowned tax experts, such as Reuven S. Avi-Yonah, Yariv Brauner, Joachim English, Stephen Phua, Pasquale Pistone, David Rosenbloom, Christoph Spengel and Frans Vanistendael. The Special Issue also includes other contributions written by IBFD and in-house tax experts at Tax Analysts.

Contact information:
Sorrel Hidding, Head of Marketing: +31 (0) 613325049 or s.hidding@ibfd.org




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IBFD via Globenewswire

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs24.7.2017 22:05Pressemelding

Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response   New data demonstrate that Novavax' construct is a stable prefusogenic RSV F antigen, distinctive from other candidates, that elicits potent neutralizing antibody responses to multiple key epitopes    Path forward for a Phase 2 efficacy trial in 2018 based on signal in COPD population identified in prior older adult clinical trials    Phase 3 Prepare(TM) trial accelerating and now includes 80 sites across 11 countries allowing continuous enrollment across global seasons       GAITHERSBURG, Md., July 24, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced positive topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults, new preclinical data on its RSV F Vaccin

Announcing the First U.S. Federally Regulated Exchange and Clearing House for Digital Currency Derivatives24.7.2017 21:51Pressemelding

LedgerX Receives U.S. Federal Government License to Trade, Clear and Settle Digital Currency Contracts  NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- LedgerX, the New York-based institutional trading and clearing platform for digital currencies, receives approval to operate the first U.S. federally-regulated exchange and clearing house for derivatives contracts settling in digital currencies.   A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eafba6f5-a1ce-47da-81a0-0aaacfe7caef See Related Release:  The U.S. Commodity Futures Trading Commission (CFTC) grants LedgerX LLC a Derivatives Clearing Organization license (DCO) to clear and physically settle digital currency-based financial instruments.   LedgerX will be the first federally supervised options venue for bitcoin Participants in the Le

Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer24.7.2017 15:00Pressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer. Dr. Wenstrup brings to Oxford Immunotec more than 20 years of clinical leadership experience, including over a decade within the diagnostics industry. Most recently, Dr. Wenstrup served as Executive Vice President, Chief Medical Officer, for Myriad Genetics, Inc., where he played a key leadership role and made substantial contributions across the company that helped drive and support a multi-fold increase in revenue over a decade. In addition to building and leading Myriad's clinical and medical affairs teams, Dr. Wenstrup was actively involved in the company's product development, M&A, and in-licensing activi

Minerva Neurosciences Announces Departure of Directors24.7.2017 14:30Pressemelding

WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the resignation of two members of its board of directors, Michele Ollier and Nico Vandervelpen.  Following the Company's recent public offering and the resultant improvement in its financial position, Dr. Ollier and Mr. Vandervelpen will step down to focus on their private equity activities. Their resignations are effective today. "We would like to thank Michele and Nico for their invaluable contributions to Minerva as a private company and as it has transitioned during the past three years from a venture capital-backed company to a publicly traded company that has advanced several assets into late-stage clinical development," said Marc Beer, chairman of Minerva. About Minerva Neurosciences

French Energy Operator GRDF Enlists Appian's Low-code Platform for Enterprise-wide Deployment24.7.2017 14:00Pressemelding

RESTON, Va., July 24, 2017 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announces that leading French gas distributor GRDF will deploy its latest enterprise application developed on Appian's low-code platform. The new application is designed to manage the extension of gas distribution networks in France, and will be deployed to more than 2,500 users across GRDF. This marks GRDF's fifth major application deployed on the Appian Platform.  GRDF is already benefitting from Appian's low-code applications, which enhance the customer experience and transform traditional business methods to more efficient and agile processes. Appian provides GRDF with the speed needed to capitalize on opportunities that the digital world presents, as well as the power to streamline complex business processes. Jean-Marc Wojtecki, Deputy CIO at GRDF, commented: "We solidly believe in the power of low-code for building new applications quickly. Appian allows us to innovate more effici

Placetel is named as a leading UC solution in Germany by ISG Experton Group24.7.2017 10:00Pressemelding

Placetel, Powered by BroadSoft, named as a leader in the "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS" Study recognizes broad functional spectrum and strong focus on SMEs Operation of data centers in Germany is acknowledged as a further advantage COLOGNE, Germany, July 24, 2017 (GLOBE NEWSWIRE) --  Placetel, a cloud PBX service from BroadSoft Germany GmbH, has been named by ISG/Experton Group, a leading fully integrated research, advisory and consulting company, as one of the best cloud-based solutions for Unified Communications as a Service (UCaaS) in Germany. ISG/Experton Group positioned Placetel, powered by BroadSoft, in the leadership quadrant in its provider comparison "ISG Provider Lens Germany 2017 - Cloud Transformation / Operation Services & XaaS". An infographic accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attach

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom